'Viral load' presentation slideshows

Tests and monitoring in HIV infection

UK standard of care and some other useful tests Matthew Williams UK CAB Tests and monitoring in HIV infection UK standard of care and some other useful tests Tests and monitoring in HIV infection CD4 count Viral load Resistance Therapeutic drug monitoring

1.27k views • 75 slides

Management of Patients with Immunodeficiency Disorders and HIV/AIDS

Management of Patients with Immunodeficiency Disorders and HIV/AIDS. By Linda Self. Immunodeficiency defined. Decreased or compromised abiity to respond to antigenic stimuli by appropriate cellular immunity reaction.

1.49k views • 68 slides

1.21k views • 60 slides

Review of the Medical Monitoring Project Outcomes of Interest Pilot Year Data

Review of the Medical Monitoring Project Outcomes of Interest Pilot Year Data. MMP PAB/CAB Meeting May 31, 2007 Department of State Health Services Epidemiology & Surveillance Unit Sylvia L. Odem, MPH Project Coordinator . Acknowledgements to the Pilot Year TX-MMP Team:.

726 views • 55 slides

World Bank Training Program on HIV/AIDS Drugs Training Module 3 Selection and Quantification

783 views • 49 slides

Eric S. Rosenberg, M.D.

Eric S. Rosenberg, M.D. Associate Professor of Medicine Massachusetts General Hospital Harvard Medical School erosenberg1@partners.org. 47 year old male . Present to MGH ED with an 8 day history of : Fever to 102.5 Headache Photophobia Myalgias and arthralgias Nausea and vomiting

439 views • 30 slides

HIV/AIDS

570 views • 29 slides

Alex Coutinho MD MPH DTM&H Jonathan Mermin MD MPH et al CROI Boston, USA February 2008

Efficacy of routine viral load, CD4 cell count, and clinical monitoring of adults taking antiretroviral therapy in Rural Uganda. Alex Coutinho MD MPH DTM&H Jonathan Mermin MD MPH et al CROI Boston, USA February 2008. Obstacles to rural HIV care.

546 views • 28 slides

Treatment Failure

Treatment Failure. HAIVN Harvard Medical School AIDS Initiative in Vietnam. Learning Objectives. At the end of this presentation, participants should be able to: Recognize the importance of diagnosing treatment failure Know the definitions of treatment failure

411 views • 20 slides

Module 1: Overview of HIV Infection

Module 1: Overview of HIV Infection. Unit 2: Epidemiology of HIV Infection. Objectives. At the end of this session the participant should be able to: Describe the history of HIV Explain the global, regional, national and local distribution of HIV

342 views • 20 slides

VJ Sekar, 1 E De Paepe, 2 B Van Baelen, 2 F Tomaka, 1 S Spinosa-Guzman, 2 M De Pauw, 2 T Vangeneugden, 2 A Vandevoo

Effect of extrinsic and intrinsic factors on the pharmacokinetics of darunavir/ritonavir (DRV/r) in HIV-1 patients: results of a randomised, controlled, Phase III study (TITAN).

465 views • 20 slides

Viral load, does it matter? Probably so.

Viral load, does it matter? Probably so. Tim Pruett, MD University of Virginia. The problem of viral load/activity. An important predictor of transplant outcomes in patients with HBV and HCV HIV is an unknown, should we be mixing groups?

403 views • 18 slides

2009 Revisions of WHO recommendations on use of Antiretroviral Therapy (ART)

458 views • 18 slides

The Local and Global Impact of HIV

The Local and Global Impact of HIV. I can explain the basic facts about HIV transmission. I understand drug treatments associated with living with HIV and HIV prevention. I understand and have empathy toward the experience of people living with HIV. What do you know about HIV? What is HIV?

255 views • 17 slides

Measuring Adherence

Measuring Adherence. Jonathan Shuter, M.D. Treatment Adherence Network Meeting 2/27/01. Measuring Adherence--One Extreme.

353 views • 17 slides

Severe Acute Respiratory Syndrome (SARS)

Severe Acute Respiratory Syndrome (SARS). Presented by Parth Dave & Kuan-Mei Lin December 2, 2005 . Outbreaks. In November 2002, highly contagious and severe atypical pneumonia were observed in the Guangdong Province of southern China

663 views • 16 slides

Innovative Biotech Ltd Nigeria

Innovative Biotech Ltd Nigeria. Dr Simon Agwale. General overview (1). Nigeria is the tenth largest country in the world and the most populous in Africa. It is situated within sub Saharan Africa which harbors about 67% of the world HIV/AIDS burden

425 views • 16 slides

Providing community ART in a time of conflict: Pilot projects from Central African Republic

Providing community ART in a time of conflict: Pilot projects from Central African Republic. INTEREST Workshop 2019 Charles Ssonko MSF-UK 16 May 2019. Background on CAR. Population 4.7 million

348 views • 14 slides

Phases of HIV/AIDS

Phases of HIV/AIDS. 1. Infection 2. Window period 3. Seroconversion 4. Asymptomatic period 5. HIV/AIDS - related illness 6. AIDS. CD4 counts. Number of CD4 cells in blood provides a measure of immune system damage CD4 count reflects phase of disease CD4 count:

461 views • 11 slides

1 st International Standard for HIV-1 RNA NIBSC Code 97/656

1 st International Standard for HIV-1 RNA NIBSC Code 97/656. CBER, CLB and NIBSC collaborated in development of HIV-1 International Standard for NAT Three candidate standards evaluated in collaborative study

313 views • 7 slides